|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 3 of 31 found articles
| Title: |
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial |
| Author: |
Borchmann, Peter Ferdinandus, Justin Schneider, Gundolf Moccia, Alden Greil, Richard Hertzberg, Mark Schaub, Valdete Hüttmann, Andreas Keil, Felix Dierlamm, Judith Hänel, Mathias Novak, Urban Meissner, Julia Zimmermann, Andreas Mathas, Stephan Zijlstra, Josée M Fosså, Alexander Viardot, Andreas Hertenstein, Bernd Martin, Sonja Giri, Pratyush Scholl, Sebastian Topp, Max S Jung, Wolfram Vucinic, Vladan Beck, Hans-Joachim Kerkhoff, Andrea Unger, Benjamin Rank, Andreas Schroers, Roland zum Büschenfelde, Christian Meyer de Wit, Maike Trautmann-Grill, Karolin Kamper, Peter Molin, Daniel Kreissl, Stefanie Kaul, Helen von Tresckow, Bastian Borchmann, Sven Behringer, Karolin Fuchs, Michael Rosenwald, Andreas Klapper, Wolfram Eich, Hans-Theodor Baues, Christian Zomas, Athanasios Hallek, Michael Dietlein, Markus Kobe, Carsten Diehl, Volker |
| Appeared in: |
Lancet |
| Paging: | Volume 404 () nr. 10450 pages 341-352 |
| Year: |
2024 |
| Contents: | |
| Publisher: |
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 3 of 31 found articles
| << previous | next >> |